Business Context and Reporting Period
This Form 8-K is filed by Marathon Patent Group, Inc. (the "Company") for the reporting period of May 6, 2014. The Company is a Nevada corporation engaged in patent licensing activities. The report details a material definitive agreement entered into by CRFD Research, Inc., a wholly owned subsidiary of the Company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the execution of a legal agreement rather than financial performance metrics.
Material Changes
On May 6, 2014, the Company's subsidiary, CRFD Research, Inc., entered into a patent license agreement (the "CRFD IP Agreement") with RPX Corporation. Under this agreement, certain patents are to be licensed to RPX upon the closing of the transaction.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to file the full CRFD IP Agreement as an exhibit to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2014.
- Confidentiality: The Company plans to seek confidential treatment for certain terms of the CRFD IP Agreement at the time of the Form 10-Q filing.
- Risks and Contingencies: The filing notes that the description of the agreement is not complete and is qualified in its entirety by the full text of the CRFD IP Agreement, which will be filed later.
Investor Verification Checklist
- Verify the specific terms of the CRFD IP Agreement once filed in the Form 10-Q for the quarter ended June 30, 2014.
- Confirm the closing date of the transaction with RPX Corporation.
- Review the Form 10-Q to determine which terms of the agreement were granted confidential treatment.
- Assess the financial impact of the patent licensing deal once the full agreement details are disclosed.